Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 230.50
-5.54 (-2.35%)
Jul 31, 2026, 3:30 PM IST
Jagsonpal Pharmaceuticals Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 2,938 | 2,872 | 2,687 | 2,087 | 2,367 | 2,176 |
Revenue Growth | 3.87% | 6.89% | 28.76% | -11.83% | 8.79% | 15.77% |
Gross Profit Gross Profit Growth | 1,878 | 1,829 | 1,718 | 1,282 | 1,440 | 1,279 |
Operating Income Operating Income Growth | 518.68 | 486.3 | 429.4 | 216.07 | 338.85 | 239.87 |
Net Income Net Income Growth | 454.76 | 430.82 | 553.61 | 224.63 | 267.21 | 188.55 |
Earnings Per Share EPS Growth | 6.70 | 6.31 | 8.22 | 3.39 | 4.08 | 2.88 |
EPS Growth | -26.03% | -23.24% | 142.48% | -16.91% | 41.72% | 10.55% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 2,652 | 2,040 | 2,312 | 2,122 |
Rest of The World Rest of The World Growth | 34.96 | 46.61 | 55.28 | 54.26 |
Total Total Growth | 2,687 | 2,087 | 2,367 | 2,176 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,061 | 1,061 | 1,287 | 1,479 | 1,146 | 470.57 |
Total Debt Total Debt Growth | 81.65 | 81.65 | 92.39 | 89.41 | 60.01 | - |
Net Cash (Debt) Net Cash Growth | 979.55 | 979.55 | 1,195 | 1,390 | 1,086 | 470.57 |
Net Cash Growth | -18.02% | -18.02% | -14.03% | 27.96% | 130.84% | -15.07% |
Net Cash Per Share Net Cash Per Share Growth | 14.44 | 14.35 | 17.75 | 20.96 | 16.59 | 7.18 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 468.12 | 553 | 351.66 | 466.55 | 69.14 |
Capital Expenditures CapEx Growth | - | -1.48 | -3.48 | -2.48 | -3.18 | -10.49 |
Free Cash Flow Free Cash Flow Growth | - | 466.64 | 549.52 | 349.18 | 463.37 | 58.65 |
Free Cash Flow Growth | - | -15.08% | 57.37% | -24.64% | 690.06% | -78.87% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 63.90% | 63.66% | 63.92% | 61.41% | 60.84% | 58.78% |
Operating Margin | 17.65% | 16.93% | 15.98% | 10.35% | 14.31% | 11.02% |
Pretax Margin | 20.68% | 20.03% | 26.00% | 14.31% | 14.70% | 12.24% |
Profit Margin | 15.48% | 15.00% | 20.60% | 10.76% | 11.29% | 8.67% |
FCF Margin | - | 16.25% | 20.45% | 16.73% | 19.57% | 2.70% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 4.000 | 4.000 | 2.500 | 2.000 | 2.000 | 1.600 |
Dividend Per Share Growth | 60.00% | 60.00% | 25.00% | 0% | 25.00% | 300.00% |
Dividend Yield | 1.73% | 2.17% | 1.16% | 1.85% | 1.78% | 1.32% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 34.43 | 28.60 | 26.05 | 32.55 | 28.41 | 43.57 |
P/FCF Ratio | 32.61 | 26.41 | 26.24 | 20.94 | 16.39 | 140.06 |
PS Ratio | 5.18 | 4.29 | 5.37 | 3.50 | 3.21 | 3.78 |